Please wait while we load the price list

Business Wire - Coulter Pharmaceutical And SmithKline Beecham Combine Bexxar With CVP Chemotherapy in a New First-Line Clinical Trial

November 30th, 2008

Business Editors & Health/Medical Writers
SOUTH SAN FRANCISCO, Calif./PHILADELPHIA–(BW HealthWire)–April 26, 2000
Coulter Pharmaceutical (Nasdaq:CLTR) and SmithKline Beecham (NYSE:SBH) today announced a Phase II multicenter investigational trial of Bexxar(TM) …

Preparation for - Tummy Tuck / Abdominoplasty, Body Lift, or Thigh Lift

November 27th, 2008

How Should I Prepare for Tummy Tuck or Body Lift Surgery?

Prior to Surgery

The surgeon will provide very specific instructions prior to surgery so you will have an optimal and safe experience. These include- what medications to avoid to prevent excessive bleeding and bruising, required medical exams, what to eat and drink prior to surgery, and the prescription of an anti-nausea pill…

Information for Healthcare Professionals: Antipsychotics

November 21st, 2008

ROCKVILLE, Md., June 16, 2008-FDA ALERT
[6/16/2008]: FDA is notifying healthcare professionals that
both conventional and atypical antipsychotics are associated with
an increased risk of mortality in elderly patients treated for
dementia-rel…

Business Wire - Coulter Pharmaceutical and SmithKline Beecham Expand Proprietary Position With Second U.S. Patent Grant This Year

November 14th, 2008

Business Editors, Health/Medical Writers
SOUTH SAN FRANCISCO, Calif. & PHILADELPHIA–(BW HealthWire)–July 26, 2000
Coulter Pharmaceutical (Nasdaq:CLTR) and SmithKline Beecham (NYSE:SBH) today announced that the U.S. Patent and Trademark Office has issued another patent relating to CD20 antibody therapy for the treatment of lymphoma.
The newest patent, number …

Get Rid of Migraines

November 9th, 2008

Migraine is a type of headache and a recognised medical condition. Migraine is widespread in the population. In the U.S., 18% of women and 6% of men report having had at least one migraine episode in the previous year. Migraines afflict about 30 million people in the United States. They may occur at any age, but usually begin between the ages of 10 and 40 and diminish after age 50. Some people experience several mig…

Shake Off the Shakes

November 4th, 2008

You don’t have to be Michael Jackson to experience tremors or shaking hands. Most people have them at one time or another and their causes are as varied as the moves Jackson can make.

If your hands tremble, it could be the result of fatigue or tension. Mine usually does after long hours of writing. Others get the shakes after ironing clothes or doing heavy manual labo…

Business Wire - Coulter Pharmaceutical and SmithKline Beecham Announce the Submission of a Biologics License Application for Bexxar to FDA

October 31st, 2008

Business Editors/Health Writers
SOUTH SAN FRANCISCO, Calif. & PHILADELPHIA–(BW HealthWire)–Sept. 18, 2000
Coulter Pharmaceutical, Inc. (Nasdaq:CLTR) and SmithKline Beecham (NYSE:SBH) today announced the re-submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for Bexxar(TM) (tositumomab, iodine I 131 tositumomab). The companies are see…

MAMM - Is There A Good Doctor In The House?

October 29th, 2008

“You really should see my doctor. He has a terrible personality, but he’s the best.”
I’ve never quite understood this admonition to choose between expertise and humanity, particularly because I know many doctors in possession of both. If, as we are told, our recovery depends in part on our maintaining a Zenlike disposition, why are we so often urged to accept d…

MedSurg Nursing - Stroke following vertebral artery dissection: a case study

October 25th, 2008

D.L., a 34-year-old white male, presented to the emergency room of a community hospital complaining of vomiting, dizziness, double vision, finger numbness, and a severe frontal and occipital headache. He was treated…

Business Wire - Coulter Pharmaceutical Reacquires Rights to Bexxar Outside of the U.S. from SmithKline Beecham; The Companies Expand Collaboration in the U.S

October 24th, 2008

Business Editors/Health & Medical Writers
SOUTH SAN FRANCISCO, Calif. and PHILADELPHIA–(BW HealthWire) –April 25, 2000
Coulter Pharmaceutical (Nasdaq:CLTR) and SmithKline Beecham (NYSE:SBH) today announced an amendment to their collaboration for Bexxar(TM) (tositumomab, iodine I 131 tositumomab), Coulter’s lead investig…